Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma

NCT02626962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma

Interventions

DRUG: ipilimumab
DRUG: Nivolumab

Sponsor

Grupo Español Multidisciplinar de Melanoma

Collaborators

[object Object]